Update on the safety profile of certolizumab pegol in rheumatoid arthritis: an integrated analysis from clinical trials

OBJECTIVE: To report the long-term safety data of certolizumab pegol (CZP) in rheumatoid arthritis (RA) accumulated as of 30 November 2011. DESIGN: Data from 10 completed randomised controlled trials (RCT) of CZP in RA and several open-label extensions (OLE) were pooled across all doses. Reported ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Bykerk, V P, Cush, J, Winthrop, K, Calabrese, L, Lortholary, O, de Longueville, M, van Vollenhoven, R, Mariette, X
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283674/
https://www.ncbi.nlm.nih.gov/pubmed/24092417
http://dx.doi.org/10.1136/annrheumdis-2013-203660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283674/
https://www.ncbi.nlm.nih.gov/pubmed/24092417
http://dx.doi.org/10.1136/annrheumdis-2013-203660

Ejemplares similares